GSK Acquires Nuvalent to Expand Oncology Pipeline | Lucid Diligence Brief
GSK strengthens its oncology portfolio with Nuvalent acquisition, adding…
Oncology Today—June 2, 2026
This week’s Oncology update highlights precision-oncology momentum across…
Lucid Diligence Brief: OSE Immunotherapeutics refocus on lusvertikimab and Tedopi
Lucid Diligence Brief: OSE Immunotherapeutics refocus on lusvertikimab and…
Lucid Diligence Brief: Jacobio and AstraZeneca pan-KRAS asset deal
Lucid Diligence Brief: Jacobio and AstraZeneca pan-KRAS asset deal Professional…
Lucid Diligence Brief: Triana Biomedicines $120M Series B for TRI-611 in ALK+ NSCLC
Lucid Diligence Brief: Triana Biomedicines $120M Series B for TRI-611 in ALK+…
Oncology Today—November 17, 2025
This week in oncology, we spotlight the most relevant updates, approvals, and…
Oncology Weekly News - September 15th 2025
Oncology Update : Ozuriftamab Phase 3, Libtayo 5-Year Data, INLEXZO Approval…
Cell and Gene Therapy Weekly News - September 11th 2025
Gene & Cell Therapy Update: Lilly Obesity Deal, RMAT for Stargardt, XLRP…
Oncology Weekly News - September 8th 2025
🔬🧬 Oncology Updates: Tagrisso survival boost, J&J combo win and More…
Oncology Weekly News - September 1st 2025
🔬🧬 Oncology Updates: Tevimbra EU Approval, KRAS G12C Fast Tracks, HER2-Low…
Oncology Weekly News - August 25th 2025
🔬🧬 Oncology Updates: Iza-bren FDA Breakthrough, Inhaled KB707 Data, AI in…
Oncology Weekly News - August 11th 2025
🔬🧬 Oncology Updates: New Brain Cancer Therapy, HER2 NSCLC Breakthrough, Global…